SEBI Registration No - INA000003197 Investment in stock and commodity market are subject to market risk. Please do not trade on those tips which are not provided through SMS.

Blog

ZydusBiologics

Zydus Healthcare buys office property in Mumbai

Pharma major in the country, Zydus Healthcare, has bought 80000 sq. ft., building on western express highway in Goregaon East, Mumbai from the Walia Group.
This is one of the biggest office property deals in Mumbai, wherein the deal value stands at Rs 172 cr.
The Cadila Healthcare Limited stock is seen to be trading rangebound for past one month. The stock closed with gains of 0.6% on Monday on BSE.
The major healthcare stocks showed weakness on Monday. Pharma majors like Sun Pharma, Lupin, Aurobindo, Glenmark and Ajanta Pharma were together dragging down the BSE Healthcare index in Monday’s trading session.
BSE Healthcare index closed on Monday with a loss of 0.8% at the 15229 level.
Stock View:
Cadila Healthcare Ltd ended at Rs 448.9, up by Rs 2.7 or 0.61% from its previous closing of Rs 446.2 on the BSE.
The scrip opened at Rs 442.5 and touched a high and low of Rs 452.5 and Rs 439.15 respectively. A total of 48965(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs 45955.81 crore.
The BSE group ‘A’ stock of face value Rs 1 touched a 52 week high of Rs 460 on 17-Feb-2017 and a 52 week low of Rs 305 on 12-Apr-2016. Last one week high and low of the scrip stood at Rs 456.5 and Rs 432.9 respectively.
The promoters holding in the company stood at 74.79 % while Institutions and Non-Institutions held 17.18 % and 8.03 % respectively.
The stock traded above its 50 DMA.